Discover
etrolizumab (RG7413) / RocheA Study of Etrolizumab-Based Induction Therapy Combinations Followed by Etrolizumab Maintenance Therapy in Patients with Moderate-To-Severe Ulcerative Colitis (clinicaltrialsregister.eu) - Sep 12, 2020 - P3; N=372; Ongoing; Sponsor: F. Hoffmann-La Roche Ltd
Skyrizi (risankizumab) / AbbVie, Boehringer IngelheimA Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment (clinicaltrials.gov) - Sep 11, 2020 - P3; N=618; Active, not recruiting; Sponsor: AbbVie; Recruiting --> Active, not recruiting
